This list is particularly incomplete where children's problems and prevention programs are concerned. A separate Division 12 task force constituted by President Gerald Koocher and chaired by Suzanne Bennett Johnson is focusing on these issues. Moreover, there are areas of the literature that are currently being examined by members of the task force who have not yet completed their reviews (e.g., family therapy, treatment of alcoholism). Treatments from these areas will be considered in the next edition of this report.
2. This list does not substitute for educators' and practitioners' own decisions about what is the most appropriate treatment for a given client. We have made no recommendations about what is the best treatment for a particular problem. The problem for which the client is seeking treatment is only one of the factors that need to be considered in selecting among treatment interventions. Applications of manualized treatments to practice require flexibility and adaptation to the requirements of each case and setting.
3. We have drawn up this list based on criteria we set. The reader may disagree. As part of the scientist-practitioner tradition of clinical psychology, we would hope that clinical programs are training their students specifically in the evaluation of the efficacy of psychological interventions and that postdoctoral practitioners continue to evaluate treatments based on the empirical merits. In short, we encourage readers to use our list as a starting point, but to make their own judgments. We have clarified our criteria since the last task force report (1995) and hence include the table of criteria again here. See Table 1 .
In particular the reader may wish to know how we resolved cases where there were conflicting data about the efficacy of a treatment. Typically we relied on metaanalyses. When these were not available, we came to a judgment based on the quality of the methodology across trials and the preponderance of the data.
Also important is what variables were tested in analyses of treatment efficacy. We concentrated on tests of change in the defining problem or symptoms, although a number of investigators also demonstrated improvement on broader tests of psychological functioning and quality of life. Thus, for example, if a study focused on treatment of alcoholism via couples therapy, we did not consider the treatment efficacious if marital satisfaction improved but alcoholrelated problems did not. (Note that this study does provide additional evidence for the efficacy of the treatment where marital discord is concerned.) 4. Included in the current edition of the list are new entries as well as the original entries, which in some cases have been modified on the basis of additional information or the correction of errors. New or modified entries are marked with an asterisk in Table 2 . We have organized Table 2 by problem area and have identified which treatments we have found that are effective for specific difficulties. (These were not restricted to diagnoses, but could include any reliably specified problem for which a client might seek assistance.) We excepted token economy programs from the problemspecific restriction because the problem behaviors to which token economies have been applied are legion (see Kazdin, 1977) .
5. For treatments to be considered for this list, we require that the supporting research have been conducted with treatment manuals (with specific and rare exceptions). There are two reasons for this. First, it makes for better research design and interpretable results. Second, it allows readers to know what the treatment actually entailed and therefore what has been supported. For example, there are many types of dynamic therapy. When we indicate that brief dynamic therapy is probably efficacious as an adjunctive treatment for opiate addition (Woody, Luborsky, McLellan, & O'Brien, 1990) , we mean specifically the treatment described in the manual employed in that research, which was Supportive-Expressive Psychotherapy as adapted for substance abuse (Luborsky, Woody, Hole, & Vellecho, 1995) . Whether a very different type of dynamic therapy like Davanloo's (1980) would be effective remains to be studied and should not be assumed. This is equally the case for behavioral and cognitive therapies. For example, relaxation training and exposure and response prevention are both behavior therapies, but the latter is significantly more efficacious than the former in the treatment of obsessivecompulsive disorder (Rachman, Hodgson, & Marks, 1971) . Thus, there are many interventions that fall under a rubric in the table, and the brand names are not the critical identifiers. The manuals are.
6. Depending on the problem treated, the psychological intervention cited in Table 2 may have been in addition to other treatment the patient received (e.g., medication for psychotic patients, drug counseling, medical interventions for pain) or the sole treatment. In case of the former we determined that the psychological intervention had a positive impact above and beyond the effects of the other interventions. In considering use of these treatments, the reader needs to consult the papers and manuals to determine when the psychological intervention should be considered part of a broader treatment approach.
Client Characteristics and the Interpretation of EVT
Findings Delivery of psychotherapy services and estimates of the likelihood that a given EVT will be helpful to a particular client are made difficult by the myriad potential variables that might affect a given client's response to treatment. In this section, we will consider two such broad areas of concern: using EVTs with ethnic minority clients and Aptitude X Treatment Interactions.
Treatment of Ethnic Minority Clients
Have EVTs been established for ethnic minority populations? Analogue investigations aside, we know of no psychotherapy treatment research that meets basic criteria important for demonstrating treatment efficacy for ethnic minority populations --namely, research in which (a) preand post treatment status is assessed for clients from one or more ethnic minority group(s), (b) clients are blocked according to their particular ethnic group membership and randomly assigned to different treatments or to treatment and control groups, (c) multiple, culturally cross-validated assessment instruments are employed, and (d) findings are replicated (see Sue, 1995; Sue, Zane, & Young, 1994) . The dearth of culturally cross-validated measures makes even beginning such research problematic.
Examining the citations for EVTs identified in the 1995 task force report, we find not a single study included tests of the efficacy of the treatment for ethnic minority populations. Most investigators did not specify ethnicity of subjects or used only white subjects. Out of about 41 studies cited, only 6-7 made any reference to race or ethnicity of subjects (e.g., DiMascio et al., 1979; Falloon et al., 1985; Foa et al., 1991; Hogarty et al., 1986; Wilfley et al., 1990) . Not one used ethnicity as a variable of interest. Recently, Chambless and Williams (1995) examined whether one EVT, in vivo exposure for agoraphobia, was as effective for African American outpatients as for white ones. These preliminary data suggested it was not. More research is clearly needed before conclusions can be drawn, but the point is that the data do not, at present, exist, or at least have not been reported.
What implications can be drawn for research and practice with ethnic minority populations? Strictly speaking, then, the efficacy of EVTs has not been established with ethnic minority populations. This is unfortunate for several reasons. First, the United States is among the most diverse nations in the world, and most therapists will have to deal with clients from very different cultural backgrounds. Second, there is indication that mental health needs of ethnic minority populations are high, and that these groups have been underserved or inappropriately served by the mental health profession. Third, the lack of rigorous research on the efficacy of treatment for culturally diverse populations is poor science because it shows a lack of attention to the limits of generalization from the samples studied. Obviously, those treatments that have been validated for one population may be valid for another. However, as scientists, we cannot assume that the effects will be similar. Outcomes must be demonstrated by empirical research, especially in view of the controversies in the literature concerning the necessity of considering cultural factors in treatment.
Recommendations. If we are to base practice on research findings, then we must begin to conduct rigorous outcome research on diverse cultural groups. Elsewhere Sue and colleagues (e.g., Sue et al., 1994) have addressed practical (e.g., finding adequate samples of minority groups) as well as methodological (e.g., finding cross-culturally valid assessment measures) problems in research involving ethnic minority groups. We need innovative and effective strategies to increase our ability to study ethnic minority groups and to draw meaningful conclusions. For now, we offer the following suggestions:
1. Ethnicity of subjects should be specified in all studies. NIMH has issued requirements concerning the inclusion of minorities in clinical research, but this only affects NIMH-funded research. Journal editors might encourage all investigators to report the ethnicity of their samples.
2. Investigators should be given incentives for studies of ethnicity and treatment. For example, NIMH provides supplements to individuals from underrepresented groups for work on existing research grants. These supplements could be used for research on ethnicity.
3. We encourage researchers who have subjects from different ethnic groups in their studies to report the effect sizes on major outcome variables by ethnicity. Thus, although it is unlikely that any one researcher would have a large enough sample to draw meaningful conclusions about the efficacy of a given treatment for minority clients, data would accrue in the literature and ultimately permit metaanalysis.
4. We should more clearly define what barriers are preventing researchers, especially more senior and experienced ones, from conducting research on diverse populations. For example, does the problem stem from methodological and conceptual difficulties, lack of interest, controversies in ethnic research, or practical problems alone? The NIMH Office of Research on Minority Health has prepared an outreach notebook to assist investigators, but whether the federal program emphasis will yield a harvest of new data is yet to be determined.
5. Given the lack of efficacy data, should we continue offering psychotherapy to diverse populations? Yes. We have a responsibility to provide services, even without definitive research findings on which to base services. Of greater importance is the need to alleviate suffering to the best of our ability and to the best of our knowledge, based on generalization from white samples. Aptitude X Treatment Interactions To date the task force's efforts have been focused on identifying treatments that are efficacious for particular problems or diagnoses. This is a step away from the uniformity myth that all clients are the same and can be successfully treated with the same procedures, yet it does not go far enough. When practitioners select from among efficacious treatments for a given client, they must consider not only the problem for which the person seeks treatment, but also any personal qualities of the client that may affect which treatment will be most helpful for this particular person. This poses formidable problems because a large number of factors might shape any individual's response to a given type of treatment (Beutler, 1991) . Nonetheless, creative research in this area is beginning to emerge and may be found in studies of Aptitude X Treatment Interactions (ATIs).
As noted by Smith and Sechrest (1991) , research in this area is notoriously difficult because psychotherapy studies usually lack the power to detect such interactions, and ATIs tend to be difficult to replicate. Many of the findings have been what Beutler (1991, p. 226 ) calls "happenstantial" rather than emerging from tests of theory-driven, a priori hypotheses. For the purposes of this report, we established initial criteria for identifying ATIs in conjunction with those used in Table 1 . We suggest that (a) the aptitude (client) variable must be assessed with reliable and valid measures; and (b) that differential efficacy must be shown such that the clients who are high on the aptitude in question fare better or worse in one of the specified treatments than those who are low on the aptitude; that is, that a significant interaction is shown. Alternatively, a large number of single case design experiments might be conducted to show that the treatment effect occurs for clients showing the aptitude, but not for those who do not. In reality, all the research we located employed group designs.
Our intention was to include yet another table in this report in which we would list the replicated ATIs established through sound research. We found that such a table would have been premature. Nonetheless, because of the great practical importance of this topic, we review here the findings that are emerging and that may prove useful to the clinician. We hope that in our next report, more definitive statements may be possible.
Beutler (1991) has suggested that, although the number of client characteristics that might be supposed to affect treatment outcome seems infinite, they actually boil down to three or four. For example, one of the characteristics attracting the most research is resistance or reactance. Would we predict that reactant clients would fare poorly in treatment in general? Or only with particular treatments or particular interventions within treatments? Beutler has argued that, by examining the strategies used in various types of therapy, rather than the overall labels, the researcher may form clear hypotheses about possible ATIs.
An emerging body of research suggests that reactance is an important characteristic for therapists to consider in the selection of strategy. Beutler, Engle et al. (1991) found that depressed patients low on reactance fared better in cognitive therapy than in a telephone-based supportive/self-directive therapy condition. On the other hand, patients high on reactance did better if assigned to the supportive/selfdirective condition, even though this was a rather minimal treatment. The authors hypothesized that reactant clients respond negatively to the directive nature of cognitive therapy. In support of this notion, Beutler, Mohr et al. (1991) briefly described similar findings from a German study in which reactant clients in another directive therapy (behavior therapy) did worse than reactant clients who received (presumably nondirective) client-centered therapy. Findings for the low reactance clients were the reverse.
Beutler and colleagues' findings are reminiscent of those by Shoham and colleagues. In a study with procrastinating college students Shoham-Salomon, Avner and Neeman (1989) found that highly reactant clients benefited more from paradoxical instructions than from a straightforward behavioral intervention. These findings were replicated with clinic patients with sleep-onset insomnia (Shoham, Bootzin, Rohrbaugh, & Urry, 1995) . Thus, a growing body of research suggests that we need to select treatment approaches for reactant patients with especial care to possible ATIs. It seems reasonable to hypothesize at this point that reactant clients respond negatively to the directive aspects of cognitive and behavioral therapies, but additional research is needed to verify this process hypothesis.
Three studies suggest another client characteristic to consider is impulsivity/low socialization. (These concepts are highly correlated and so are grouped here.) Beutler, Engle et al. (1991) determined that depressed clients high on impulsivity did better in cognitive therapy than in supportive/self-directive therapy (and the converse for low impulsive clients). These findings suggest that the structure of cognitive therapy might assist clients who are deficient in impulse control. Two studies on this question have been conducted with alcoholic samples. In research on posthospitalization alcoholism treatment, Kadden, Cooney, Getter, and Litt (1989) found some (albeit inconsistent) evidence that low socialization clients improved more in structured coping-skills training groups, whereas high socialization clients did better in Yalom-type groups which were more free-form and focused on interactions among group members. Testing cognitive behavioral treatment with and without a relationship enhancement focus for alcoholic outpatients, Longabaugh et al. (1994) found that patients with antisocial personality disorder (low socialization/high impulsivity) who were in the relationship enhancement condition drank more heavily during the follow-up period than those who had received cognitive behavior therapy alone. Relationship enhancement neither added to nor detracted from treatment response of the patients without antisocial personality. Although solid conclusions are premature, these data suggest that, given two treatments of equal general efficacy, clients' needs for structure and an individual treatment focus may be an important determinant of differential response.
Finally, whether patients in treatment for chemical abuse and dependence need psychotherapy or simply drug or alcohol counseling has been a matter of some contention. ATI research may ultimately provide some answers to this question. For example, Woody et al. (1990) found that opiate addicts who scored low on measures of psychiatric severity fared equally well in drug counseling with or without additional psychotherapy (dynamic or cognitive). On the other hand, those with higher psychiatric severity improved more if they received psychotherapy in addition to drug counselling. Kadden et al. (1989) found a different type of ATI with psychiatric severity for their alcoholic population. Patients with more severe psychiatric symptoms fared better in structured coping skills training groups whereas those with less severe symptoms did better in the interactional groups.
In a final analysis, Kadden et al. (1989) examined whether the clinicians who had treated their alcoholic subjects as inpatients were able to predict which aftercare program would be more efficacious for which patient. They were not. This is discouraging in that, at present, all we have to rely upon is our clinical judgment. However, the data we have reviewed, although preliminary, offer hope that, with careful, prospective, and theory-driven research, reliable ATIs may be established which will help guide the practitioner in determining what treatment is best for what client and, thus, to maximize the efficacy of treatment.
Ethics, Science, and Clinical Interventions Psychology is a science. Seeking to help those in need, clinical psychology draws its strength and uniqueness from the ethic of scientific validation. Whatever interventions that mysticism, authority, commercialism, politics, custom, convenience, or carelessness might dictate, clinical psychologists focus on what works. They bear a fundamental ethical responsibility to use where possible interventions that work and to subject any intervention they use to scientific scrutiny.
Among the major aspects of this ethic is, first, that clinical psychologists are active, competent consumers of the research literature. In this document (see Tables 1 and 2 ) we publish our criteria for treatment efficacy and a list of treatments meeting these basic criteria. However, we urge practitioners not to consider a treatment's inclusion on this list as a substitute for their own judgment. That an experiment involving an intervention yielded a significant statistic is not, of course, a necessary and sufficient reason to conclude that the intervention has been adequately validated for a given purpose with a given population under given circumstances. It is important to consider such factors as the size and nature of the sample, the methodology, the nature of statistical inferences, the clinical significance of the change observed, and other facets. For example, is the validating evidence free of such fundamental errors as overlooking potentially confounding variables or interactions, using a design with insufficient power, failing to adjust alpha when apparently significant results are based on a large number of tests, and concluding that insignificant differences among small groups prove the null hypothesis (i.e., demonstrate the equivalence of treatments), or overgeneralizing the results? Have the findings been independently replicated? Have they been published in peerreviewed scientific and professional journals? Practitioners cannot avoid the ethical responsibility to consider such factors when deciding whether treatments should be used with a specific population. Additional points beyond the ones we have raised have been outlined by a task force appointed by the APA Boards of Professional and Scientific Affairs, the Task Force on Psychological Intervention Guidelines (1995) . The template developed by this group is well worth the practitioner's study.
Second, clinical psychologists must remain current and read beyond a specific area. The research literature is always evolving rapidly. Interventions showing initial promise may be shown by later, more elaborate research to be useless or perhaps even harmful under certain conditions. Subsequent research, while continuing to validate the intervention, may show alternate interventions to be even more effective, efficient, or safe. To read only in a specific area is to foster ignorance of other areas. Clinicians who read only behavioral, cognitive, dynamic, feminist, pharmacological, or any other specific area of research will likely remain unaware of empirically supported interventions that might be relevant to a wide variety of patients. To take an extreme and hypothetical example, therapists might know of only one intervention consistent with their theoretical orientation that has been empirically supported for a specific problem. Let's say research has shown it to be efficacious in 73% of the cases after a 3-year course of treatment. Are those therapists acting ethically if, because they do not read outside their own area of interest, they remain ignorant of an intervention associated with another theoretical orientation that has been repeatedly shown to be effective in 94% of the cases after a 5-week course of treatment?
Third, clinical psychologists bring information about empirically supported treatments to bear when addressing their patients' legal and ethical rights to informed consent to treatment and informed refusal of treatment. As part of the consent process, clinicians should make sure that clients understand what the treatment can be reasonably expected to accomplish and in what period of time, what any negative effects of the treatment might be, what other treatments might be considered, and whether these would be expected to be more or less helpful and more or less costly. Clinicians who remain uninformed about the research literature are ill-equipped to discuss these issues with clients and thus to discharge their ethical obligation. (For a further discussion, see Pope & Vasquez, 1991) . Conclusion This is an interim report in an on-going process. We invite readers' feedback, notations of errors, and suggestions for treatments for the Task Force on Psychological Interventions to consider (with accompanying supportive journal articles or citations when possible). Sanderson and Woody (1995) have published a list of training materials for EVTs identified by the first task force report (1995) , and Sanderson is also editing a series of articles for this journal describing each EVT. We expect to continue these efforts and to include materials and articles pertinent to EVTs identified in this report. We would welcome readers' assistance in identifying training materials and supervision. 
The Task Force on Promotion and Dissemination of
Psychological Procedures adopted the term "empirically validated treatments" for psychological interventions meeting its criteria. In discussions about the report, the term "empirically supported treatments" was suggested as more felicitous, and we agree that this is a preferable term. The term "validation" might be taken to mean that we believe research on a treatment is complete (see Garfield, in press), although the task force (1995) was at pains to avoid this implication in its report. We retain the label EVTs to avoid confusion at this point but caution the reader to keep in mind that validation is an on-going process. 
